Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022
Date: Apr-2016 | Id: MACRC-0052 | Geographical Scope: Global | Publisher: DPI Research
Diabetes Reusable Insulin Pen Market is likely to reach more than US$ 3 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022. Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of reusable insulin pen devices. China is expected to lead the reusable insulin pen market with a total market share of over 50% by 2022. Germany has shown its potential to become leading #2 market with more than XX% market share in 2016 and is expected to maintain its #2 position during the forecast period. United States is expected to become the third largest reusable insulin pen market by 2022. The research report titled “Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022” examines the market, demand, competitive landscape and trends of the ten major markets of the reusable insulin pen market. The report provides an in–depth analysis of overall diabetes population and insulin users. It provides essential insights into reusable insulin pen market and users for the top 10 countries, comprising the US, the UK, France, Italy, Spain, Germany, Japan, China, India and Brazil until 2022. The report also explores detailed description of growth drivers and barriers of the reusable insulin pen market. The report concludes with the profiles of major players in the insulin pen market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the insulin pen market. All the Ten Major Markets(10MM) Covered in the Report Have Studied from 4 Viewpoints 1. Overall Diabetes Population (2011 – 2022) 2. Insulin Users (2011 – 2022) 3. Reusable (Cartridge) Insulin Pen Users (2011 – 2022) 4. Reusable (Cartridge) Insulin Pen Market (2011 – 2022) Ten Major Markets(10MM) Covered in the Report are as follows: 1. United States 2. United Kingdom 3. France 4. Italy 5. Spain 6. Germany 7. Japan 8. China 9. India 10. Brazil Key Companies Covered in the Report are as follows: 1. Novo Nordisk 2. Eli Lilly 3. Sanofi 4. Owen Mumford 5. Ypsomed 6. Biocon Ltd.
Table of Contents 1. Executive Summary 2. Reusable (Cartridge) Insulin Pen Market Environment & Trend (2011 – 2022) 2.1 Reusable (Cartridge) Insulin Pen Users 2.2 Reusable (Cartridge) Insulin Pen Market 3. Reusable (Cartridge) Insulin Pen Market Share Analysis (2011 - 2022) 3.1 Reusable (Cartridge) Insulin Pen Users Share 3.2 Reusable (Cartridge) Insulin Pen Market Share 4. Reusable (Cartridge) Insulin Pen Market Drivers and Barriers 4.1 Market Drivers 4.2 Market Barriers 5. Reusable (Cartridge) Insulin Pen Market in Top Ten Countries – Geographical Landscape 5.1 United States 5.1.1 Overall Diabetes Population 5.1.2 Insulin Users 5.1.3 Reusable (Cartridge) Insulin Pen Users 5.1.4 Reusable (Cartridge) Insulin Pen Market 5.2 Germany 5.2.1 Overall Diabetes Population 5.2.2 Insulin Users 5.2.3 Reusable (Cartridge) Insulin Pen Users 5.2.4 Reusable (Cartridge) Insulin Pen Market 5.3 France 5.3.1 Overall Diabetes Population 5.3.2 Insulin Users 5.3.3 Reusable (Cartridge) Insulin Pen Users 5.3.4 Reusable (Cartridge) Insulin Pen Market 5.4 Italy 5.4.1 Overall Diabetes Population 5.4.2 Insulin Users 5.4.3 Reusable (Cartridge) Insulin Pen Users 5.4.4 Reusable (Cartridge) Insulin Pen Market 5.5 Spain 5.5.1 Overall Diabetes Population 5.5.2 Insulin Users 5.5.3 Reusable (Cartridge) Insulin Pen Users 5.5.4 Reusable (Cartridge) Insulin Pen Market 5.6 United Kingdom 5.6.1 Overall Diabetes Population 5.6.2 Insulin Users 5.6.3 Reusable (Cartridge) Insulin Pen Users 5.6.4 Reusable (Cartridge) Insulin Pen Market 5.7 Japan 5.7.1 Overall Diabetes Population 5.7.2 Insulin Users 5.7.3 Reusable (Cartridge) Insulin Pen Users 5.7.4 Reusable (Cartridge) Insulin Pen Market 5.8 China 5.8.1 Overall Diabetes Population 5.8.2 Insulin Users 5.8.3 Reusable (Cartridge) Insulin Pen Users 5.8.4 Reusable (Cartridge) Insulin Pen Market 5.9 India 5.9.1 Overall Diabetes Population 5.9.2 Insulin Users 5.9.3 Reusable (Cartridge) Insulin Pen Users 5.9.4 Reusable (Cartridge) Insulin Pen Market 5.10 Brazil 5.10.1 Overall Diabetes Population 5.10.2 Insulin Users 5.10.3 Reusable (Cartridge) Insulin Pen Users 5.10.4 Reusable (Cartridge) Insulin Pen Market 6. Key Companies Analysis 6.1 Novo Nordisk 6.1.1 Business Overview 6.1.2 Reusable Insulin Pen – Products Portfolio 6.1.3 Insulin Pen – Latest Development & Trends 6.2 Eli Lilly 6.2.1 Business Overview 6.2.2 Insulin Pen – Products Portfolio 6.2.3 Insulin Pen – Latest Development & Trends 6.3 Sanofi 6.3.1 Business Overview 6.3.2 Insulin Pen – Products Portfolio 6.4 Owen Mumford 6.4.1 Business Overview 6.4.2 Insulin Pen – Products Portfolio 6.5 Ypsomed 6.5.1 Business Overview 6.5.2 Insulin Pen – Products Portfolio 6.5.3 Insulin Pen – Latest Development & Trends 6.6 Biocon Ltd. 6.6.1 Business Overview 6.6.2 Insulin Pen – Products Portfolio
Related reports
Early Cardiogenic Shock Devices
$4500-$6600